Skip to main content

Clinical Trial Search Results

A scientist pointing to an image of a DNA chain.

Clinical Trial Search Results

Showing 190-198 out of 318 results.
NCT00736749

Umbrella Long-Term Follow-Up Protocol

Icon for trial | ALTE05N1 Umbrella Long-Term Follow-Up Protocol

This study is currently enrolling.

The overall goal of this study is to keep in contact with participants of COG clinical trials, so that up-to-date information will be available about these participants as they get older. This includes current name, contact, an ...

NCT05301140

Vivistim Registry for Paired VNS Therapy (GRASP)

Icon for trial | MT-St-REG Vivistim Registry for Paired VNS Therapy (GRASP)

This study is currently enrolling.

The purpose of this particular registry is to collect information about patients who have had a stroke and still have upper-limb difficulties. This registry includes information before and after device implant, and includes op ...

NCT06223789

VOLT-AF IDE Study

Icon for trial | ABT-CIP-10514 VOLT-AF IDE Study

This study is currently enrolling.

The Volt PFA System is an investigational device. This means that it is not yet approved for commercial use to treat atrial fibrillation, but it is approved for use in this Study. The Volt PFA System has gone through extensive ...

NCT06072781

VS-6766-301/GOG-3097 A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

Icon for trial | VS-6766-301/GOG-3097 VS-6766-301/GOG-3097 A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

This study is currently enrolling.

The main aims of this clinical study are to: Find out if the combination of avutometinib (VS-6766) and defactinib is better at prolonging the time it takes for LGSOC to grow compared to standard of care treatment options for LG ...

NCT06191796

XL092-009 A Phase 1b/2 Dose-Finding And Expansion Study Evaluating The Safety And Efficacy Of Xl092 Combined With Either AB521 OR AB521 Plus Nivolumab In Subjects With Advanced Clear Cell Renal Cell Carcinoma Or Other Advanced Solid Tumors

Icon for trial | XL092-009 XL092-009  A Phase 1b/2 Dose-Finding And Expansion Study Evaluating The Safety And Efficacy Of Xl092 Combined With Either AB521 OR AB521 Plus Nivolumab In Subjects With Advanced Clear Cell Renal Cell Carcinoma Or Other Advanced Solid Tumors

This study is currently enrolling.

To determine the recommended doses (RDs) of zanzalintinib and AB521 when administered in combination (doublet) in subjects with advanced solid tumors, and in combination plus nivolumab (triplet) in subjects with advanced ccRCC ...

NCT05766813

“A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson’s Disease”

Icon for trial | ITI-214-202 “A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson’s Disease”

This study is currently enrolling.

The purpose of this clinical research study is to look at an investigational study drug called lenrispodun. The study will investigate if lenrispodun can help to increase the time of good control of movement symptoms, that is, ...

COVID-19

Icon for trial | COVID-19 Research

At AdventHealth our goal is to continue fighting COVID-19 until it is a thing of the past. Ongoing clinical trials and research studies help by contributing knowledge to the fight against COVID-19.